ALRN

Aileron Therapeutics (ALRN)

Aileron Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALRN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	06:19	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/17	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:13	GlobeNewswire Inc.	Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/16	06:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/07	05:05	GlobeNewswire Inc.	Aileron Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/04	05:05	GlobeNewswire Inc.	Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/01	21:45	GlobeNewswire Inc.	Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/05/01	21:30	GlobeNewswire Inc.	Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/04/16	06:20	GlobeNewswire Inc.	Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/03/12	21:00	GlobeNewswire Inc.	Aileron Therapeutics Announces CEO Transition	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/03/07	07:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/29	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/16	06:05	GlobeNewswire Inc.	Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/13	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/06	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/06	03:20	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/02	06:30	GlobeNewswire Inc.	Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/02/01	06:05	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/30	06:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/30	06:10	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/29	22:48	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/29	22:46	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/29	22:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/25	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/20	06:44	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/12	06:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ALRN	Aileron Therapeutics Inc
2024/01/11	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALRN	Aileron Therapeutics Inc
2023/12/19	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc
2023/11/22	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALRN	Aileron Therapeutics Inc